Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab

Overview of attention for article published in Clinical Ophthalmology, December 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,257 followers.

Ophthopedia Update: Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab https://t.co/uKVl1SxEmY #Ophthomology #AAO2018 #Ophthotwitter https://t.co

Reply Repost Favourite